Succitimal
Succitimal Brand names, Succitimal Analogs
- (+/-)-N-Methyl-2-phenylsuccinimide
- 1-Methyl-3-Phenylsuccinimide
- Epimid
- Fenosuccimide
- Fensuccimide [DCIT]
- Fensuximida [INN-Spanish]
- Lifene
- Methylphenylsuccinimide
- Milontin
- Milontin (TN)
- Milonton
- Mirontin
- Mirotin;7 Phenosuccimide
- N-Methyl-2-phenylsuccinimide
- N-Methyl-alpha-phenolsuccinimide
- N-Methyl-alpha-phenylsuccinimide
- Phensuximid
- Phensuximide (USP)
- Phensuximide [BAN:INN]
- Phensuximidum [INN-Latin]
- Phenylsuximide
- Succinimide, N-methyl-2-phenyl-
- Succitimal
Succitimal Brand Names Mixture
- No information avaliable
Succitimal Chemical_Formula
C11H11NO2
Succitimal RX_link
No information avaliable
Succitimal fda sheet
Succitimal msds (material safety sheet)
Succitimal Synthesis Reference
No information avaliable
Succitimal Molecular Weight
189.211 g/mol
Succitimal Melting Point
72 oC
Succitimal H2O Solubility
7020 mg/L
Succitimal State
Solid
Succitimal LogP
1.079
Succitimal Dosage Forms
Capsules
Succitimal Indication
For the treatment of epilepsy
Succitimal Pharmacology
Phensuximide suppresses the paroxysmal three cycle per second spike and wave EEG pattern associated with lapses of consciousness in absence (petit mal) seizures. The frequency of attacks is reduced by depression of nerve transmission in the motor cortex.
Succitimal Absorption
Rapid and complete
Succitimal side effects and Toxicity
No information avaliable
Succitimal Patient Information
No information avaliable
Succitimal Organisms Affected
Humans and other mammals
